Us4Cure would like to offer you an opportunity to procure human biospecimens for your research projects with our team. We are dedicated to meeting our client’s expectations and provide the highest level of service to create overall value for our partners. Our team has an extensive experience in this field. Our managers participated in the Clinical Proteomics Tumor Analysis Consortium (CPTAC) Project and The Cancer Genome Atlas (TCGA) Project by the National Cancer Institute, USA. We can evaluate project feasibility, help you with the development of the project specifications and protocols, implement and monitor your project at the participating clinical site(s), and deliver collected specimens and corresponding clinical information to you in the shortest possible time. Some biospecimens could be available in the biobank. Biospecimens with specific molecular characteristics could be requested (for instance tumors / plasma with or without KRAS, EGFR, BRAF mutations, HER2 amplification and overexpression, etc.). We also offer laboratory service including preparation of blood fractions (plasma, serum, buffy coat, PBMC), isolation of viable cells from fresh dissociated tissues (including tumor infiltrating lymphocytes from fresh tumors), isolation of DNA and RNA specimens. Biospecimens are offered in several formats to meet research needs: fresh tissue, fresh frozen (FF) tissue, formalin fixed paraffin embedded (FFPE) tissue, or tissues otherwise preserved as requested, and biofluids (peripheral blood, plasma, serum, saliva, sputum, urine, bone marrow aspirate, amniotic fluid, etc.). We can procure specimens from the patients with various tumors, and hematopoietic malignancies, autoimmune diseases, cardiovascular conditions, gastrointestinal, pulmonary, neurological diseases, metabolic disorders, inherited conditions, and some infection diseases.
Depending on the project specifications, biospecimens can be procured in the USA or Eastern Europe. All clinical materials are procured using the validated protocols, in conjunction with Institutional Review Board (IRB)/ IEC approval, and in accordance with ICH requirements, and GCP regulations